0002104347-26-000001.txt : 20260112 0002104347-26-000001.hdr.sgml : 20260112 20260112154536 ACCESSION NUMBER: 0002104347-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260112 DATE AS OF CHANGE: 20260112 EFFECTIVENESS DATE: 20260112 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Gasami Therapeutics, Inc. CENTRAL INDEX KEY: 0002104347 ORGANIZATION NAME: EIN: 412408469 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-569660 FILM NUMBER: 26526601 BUSINESS ADDRESS: STREET 1: 8401 MAYLAND DR STREET 2: #5432 CITY: RICHMOND STATE: VA ZIP: 23294 BUSINESS PHONE: 4342821615 MAIL ADDRESS: STREET 1: 8401 MAYLAND DR STREET 2: #5432 CITY: RICHMOND STATE: VA ZIP: 23294 D 1 primary_doc.xml X0708 D LIVE 0002104347 Gasami Therapeutics, Inc. 8401 MAYLAND DR #5432 RICHMOND VA VIRGINIA 23294 4342821615 DELAWARE None None Corporation true 2025 Sarah Hunter-Chang 5132 Unaka Ave Charlotte NC NORTH CAROLINA 28205 Executive Officer Biotechnology No Revenues 06b false 2025-12-04 true true false 0 250000 20000 230000 false 1 0 0 20000 true Hope to pay executive officer wages from combination of grants and investments, but not sure yet how much we will get from what source. false Gasami Therapeutics, Inc. Sarah Hunter-Chang Sarah Hunter-Chang President 2026-01-12